Boehringer Ingelheim Vetmedica has announced it will expand its operations in St Joseph, Missouri, with a $150 million project. Boehringer Ingelheim Vetmedica said today it would expand its St. Joseph operations with a $150 million project that will create 124 jobs, reports The Kansas City Star.
Boehringer Ingelheim funds three research projects against swine disease PRRS with €75,000 total and three winners have been chosen for this year's awards out of more than 30 high-quality proposals.
Read and download the posters.
UK - Boehringer Ingelheim are a company dedicated to innovation in swine health and were the first company to launch a PCV2 vaccine for piglets, Ingelvac CircoFLEX, to provide early onset of immunity (from 4 weeks) with protection through to slaughter.
Get the latest news on Swine Health Subscribe to our newsletter